Balyasny Asset Management LLC United Therapeutics Corp Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$214.88 - $256.94 $3.03 Million - $3.62 Million	-14,078 Reduced 17.48%	66,460 $14.6 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $8.47 Million - $9.92 Million	39,968 Added 98.52%	80,538 $18.2 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $3.9 Million - $4.42 Million	-18,987 Reduced 31.88%	40,570 $8.96 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $3.16 Million - $4.09 Million	14,819 Added 33.12%	59,557 $13.3 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $23.7 Million - $32.3 Million	-115,039 Reduced 72.0%	44,738 $12.4 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $11.2 Million - $13.5 Million	55,173 Added 52.74%	159,777 $33.5 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $18.3 Million - $25.2 Million	104,604 New	104,604 $24.6 Million
Q4 2021 Feb 14, 2022	SELL	$184.32 - $216.08 $1.83 Million - $2.14 Million	-9,918 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $1.78 Million - $2.13 Million	9,918 New	9,918 $1.83 Million
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $2.09 Million - $2.6 Million	-12,263 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $552,798 - $627,886	3,591 Added 41.41%	12,263 $2.05 Million
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $883,416 - $1.32 Million	8,672 New	8,672 $1.32 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $660,309 - $803,906	-8,432 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $244,310 - $280,671	-3,264 Reduced 27.91%	8,432 $672,000
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $889,597 - $1.41 Million	11,696 New	11,696 $913,000
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $553,116 - $629,175	-4,860 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $45,816 - $53,594	453 Added 10.28%	4,860 $550,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $472,474 - $669,599	4,407 New	4,407 $495,000
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $379,456 - $484,096	-3,200 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $366,720 - $437,792	3,200	3,200 $375,000

Others Institutions Holding UTHR

# of Institutions

679

Shares Held

42.1M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$2.03 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.64 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.18 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.06 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$830 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account